Preeradication vaccine policy options for poliovirus infection and disease control.
about
Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination.Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria.Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes.The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmissionAn economic analysis of poliovirus risk management policy options for 2013-2052Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needsThe potential impact of expanding target age groups for polio immunization campaigns.Expert review on poliovirus immunity and transmission.Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs.National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication.The potential benefits of a new poliovirus vaccine for long-term poliovirus risk management.Dynamics affecting the risk of silent circulation when oral polio vaccination is stopped.Modeling strategies to increase population immunity and prevent poliovirus transmission in 2 high-risk areas in northern India.Poliovirus vaccination during the endgame: insights from integrated modeling.Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.Individual-based modeling of potential poliovirus transmission in connected religious communities in North America with low uptake of vaccination.Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.Modeling the dynamics of oral poliovirus vaccine cessation.Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria.Framework for Optimal Global Vaccine Stockpile Design for Vaccine-Preventable Diseases: Application to Measles and Cholera Vaccines as Contrasting Examples.World Health Organization regional assessments of the risks of poliovirus outbreaks.Modeling population immunity to support efforts to end the transmission of live polioviruses.Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations.Modeling poliovirus risks and the legacy of polio eradication.
P2860
Q34632088-BBF5EAB4-C8E6-42B5-ABD1-F6F46D98F982Q35131980-FA903C7A-3204-4D52-B7D6-DFD3583766F7Q35662053-99A6202A-EC61-4351-986F-A9C7BF43D957Q35779660-0F973F30-CDFE-4324-980C-707C090160C8Q35779856-E8085BC2-8AC9-4B48-A4AC-C6DC5F003E50Q35787304-A85165B7-E6ED-42D4-B601-816D9FE7741BQ35787331-AA2C22E9-416C-4995-9571-E573816626FCQ37568832-6891C126-2103-462F-A044-BC0BE8D83931Q38026922-15AF5B73-422B-41A1-8E18-97A6391E6B84Q38095550-A64ED244-212A-4EA4-A992-03437EEDA760Q38168905-95685E77-4F17-442C-ABCC-422963630452Q38796753-27E5B204-7E52-434E-BF11-B518FCC7D984Q38914168-3D7AF3BB-775D-41F1-80AE-ED543EA843B9Q39112948-0B21B122-2A30-4A30-8092-E3CC061D0EC3Q39258694-17EAE257-80F7-4199-A598-87E49A10B150Q41692843-C3231D6F-C9CD-407A-B806-023E4D377F37Q41700694-EC7DEBBE-3191-4D71-96F9-DE8DD58E2934Q42183578-0835985A-AF8D-4CFF-BAA1-BCADA2D9D296Q42183580-AFCC5285-F589-4DD8-98F6-920F356FCCC4Q42183582-2C03555D-40F0-47B0-9C37-8FC39BC2DAA5Q42200855-50CF0EE2-A57F-46A1-90FC-7C07CBEC67BCQ42269812-C17D0057-5096-4562-9027-5F6E28849FB9Q45326635-8F97AD32-F138-4E62-AE29-B1BE1A863162Q47556747-4DFBD2C1-F2E7-44F9-B3CA-55B954DC14F8Q53335042-BCF44BFC-86E3-4304-9D1C-BDA7DFCC9B82
P2860
Preeradication vaccine policy options for poliovirus infection and disease control.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Preeradication vaccine policy options for poliovirus infection and disease control.
@en
type
label
Preeradication vaccine policy options for poliovirus infection and disease control.
@en
prefLabel
Preeradication vaccine policy options for poliovirus infection and disease control.
@en
P2093
P2860
P50
P356
P1433
P1476
Preeradication vaccine policy options for poliovirus infection and disease control
@en
P2093
Jong-Hoon Kim
Stephen L Cochi
Steve G Wassilak
P2860
P304
P356
10.1111/RISA.12019
P577
2013-03-05T00:00:00Z